TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35395144

Group type: EXPERIMENTAL
Intervention: 3 months DAPT
Number of subjects: 307

Group type: COMPARATOR
Intervention: 12 months DAPT
Number of subjects: 307
Study: 33813559

Group type: EXPERIMENTAL
Intervention: Omidenepag isopropyl 0.002% once daily (QD)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Omidenepag isopropyl 0.002% twice daily (BID)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Comparison of BID vs QD
Number of subjects: 98
Study: 35253166

Group type: EXPERIMENTAL
Intervention: HSK3486
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 40
Study: 32696102

Group type: EXPERIMENTAL
Intervention: Topical tobramycin 0.3%/dexamethasone 0.1% plus ozonized oil eye drops, four times daily for seven days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Topical tobramycin 0.3%/dexamethasone 0.1% eye drops, four times daily for seven days
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Topical tobramycin 0.3%/dexamethasone 0.1% plus ozonized oil eye drops
Number of subjects: 80

Group type: COMPARATOR
Intervention: Topical tobramycin 0.3%/dexamethasone 0.1% eye drops
Number of subjects: 80
Study: 35191105

Group type: EXPERIMENTAL
Intervention: Accordion free gingival graft (FGG)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Conventional free gingival graft (FGG)
Number of subjects: 94
Study: 34161053

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy followed by cytoreductive surgery/hyperthermic intraperitoneal chemotherapy and adjuvant chemotherapy
Number of subjects: 0
Study: 35800020

Group type: EXPERIMENTAL
Intervention: In vivo NRT sampling group
Number of subjects: 517

Group type: COMPARATOR
Intervention: Standard smoking cessation behavioral counseling group
Number of subjects: 517
Study: 32760296

Group type: EXPERIMENTAL
Intervention: SKY Campus Happiness
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Foundations of Emotional Intelligence
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction
Number of subjects: 131

Group type: COMPARATOR
Intervention: Non-intervention control group
Number of subjects: 131
Study: 36038255

Group type: EXPERIMENTAL
Intervention: nHFOV
Number of subjects: 30

Group type: COMPARATOR
Intervention: nCPAP
Number of subjects: 30
Study: 32380522

Group type: EXPERIMENTAL
Intervention: Tweets mentioning ReachOut organization
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Tweets mentioning headspace organization
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Tweets mentioning Young and Well Cooperative Research Centre organization
Number of subjects: 715

Group type: COMPARATOR
Intervention: Randomly selected tweets (n=600)
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Tweets authored by counterparts (n=115)
Number of subjects: 715
Study: 32916500

Group type: EXPERIMENTAL
Intervention: 17 G needle
Number of subjects: 20

Group type: COMPARATOR
Intervention: 18 G needle
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Follicular ablation (FA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: CIDR-EB
Number of subjects: 20
Study: 35915512

Group type: EXPERIMENTAL
Intervention: Engage‐PA
Number of subjects: 40

Group type: COMPARATOR
Intervention: TAU+ (treatment‐as‐usual plus fitness tracker)
Number of subjects: 40
Study: 34021309

Group type: EXPERIMENTAL
Intervention: eHealth tool and psychosocial support
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: eHealth tool (app users)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: eHealth intervention
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 120
Study: 33436475

Group type: EXPERIMENTAL
Intervention: Usual care plus supervised high-intense exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care plus health education (active control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care only (population-based control group)
Number of subjects: 0
Study: 33033011

Group type: EXPERIMENTAL
Intervention: PGS2.0
Number of subjects: 268

Group type: COMPARATOR
Intervention: Conventional embryo morphology evaluation (non-PGS)
Number of subjects: 268
Study: 36260464

Group type: EXPERIMENTAL
Intervention: Sensory-adapted dental environment (SADE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular dental environment
Number of subjects: 0
Study: 33434447

Group type: EXPERIMENTAL
Intervention: Genetic risk score based on 297 single nucleotide polymorphisms
Number of subjects: 29663

Group type: EXPERIMENTAL
Intervention: Continuous model of genetic risk score
Number of subjects: 29663
Study: 33583335

Group type: EXPERIMENTAL
Intervention: Custom-fitted compression garments (CG)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 33103453

Group type: EXPERIMENTAL
Intervention: Hypoxic exercise (HE; fraction of inspired oxygen 14.0%)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Normoxic exercise (NE)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Hypoxic exercise (HE)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: All groups (H NE, P NE, H HE, P HE)
Number of subjects: 32
Study: 32559794

Group type: EXPERIMENTAL
Intervention: Juice group (200 mL of liquid enriched with carbohydrate and protein 4 hours presurgery)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (200 mL of inert solution 4 hours presurgery)
Number of subjects: 80
Study: 34592862

Group type: EXPERIMENTAL
Intervention: 300 mg oral thiamine for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Over-the-counter (OTC) oral thiamine after 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: No thiamine for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Follow-up after 6 months without restrictions
Number of subjects: 0
Study: 33693586

Group type: EXPERIMENTAL
Intervention: Oral antipseudomonal antibiotics
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Intravenous antipseudomonal antibiotics
Number of subjects: 249

Group type: COMPARATOR
Intervention: Inhaled antipseudomonal antibiotics
Number of subjects: 249
Study: 32481298

Group type: EXPERIMENTAL
Intervention: Qi Gui Yi Shen decoction
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 33849629

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 vaccine (inactivated, Vero cell)
Number of subjects: 13000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13000
Study: 32703746

Group type: EXPERIMENTAL
Intervention: 5-dose MCV vials
Number of subjects: 14

Group type: COMPARATOR
Intervention: 10-dose MCV vials
Number of subjects: 14
Study: 35940247

Group type: EXPERIMENTAL
Intervention: EXPECT (preoperative psychological intervention targeting patients' expectations)
Number of subjects: 567

Group type: COMPARATOR
Intervention: SOC (Standard of Care)
Number of subjects: 567

Group type: COMPARATOR
Intervention: SUPPORT (emotional support intervention without targeting expectations)
Number of subjects: 567

Group type: EXPERIMENTAL
Intervention: EXPECT
Number of subjects: 567
Study: 33079419

Group type: EXPERIMENTAL
Intervention: Digital guided bone regeneration procedure
Number of subjects: 30
Study: 32666061

Group type: EXPERIMENTAL
Intervention: Regular bulk-fill composite resin
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Flowable bulk-fill composite resin
Number of subjects: 78

Group type: COMPARATOR
Intervention: Negative control group (enlarged root canals, no reinforcement)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Positive control group (root canals not enlarged)
Number of subjects: 78
Study: 34973554

Group type: EXPERIMENTAL
Intervention: Self-Efficacy Prebriefing Model (SEPM)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard prebriefing
Number of subjects: 66
Study: 32546240

Group type: EXPERIMENTAL
Intervention: Diabetes conversation map (DCM)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Routine counselling (RC)
Number of subjects: 123
Study: 36494209

Group type: EXPERIMENTAL
Intervention: External graft support
Number of subjects: 224
Study: 34210922

Group type: EXPERIMENTAL
Intervention: Aloe vera toothpaste for 30 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fluoride toothpaste for 30 days
Number of subjects: 20
Study: 32798329

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention (9-week duration)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Education programme (5-week duration)
Number of subjects: 267
Study: 34261990

Group type: EXPERIMENTAL
Intervention: Upper body resistance exercise (EX)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Time-matched period (CON)
Number of subjects: 16
Study: 34596156

Group type: EXPERIMENTAL
Intervention: Pulsed magnetic therapy
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combined magnetic therapy and exercise therapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Routine medical treatment (Control)
Number of subjects: 45
Study: 32379396

Group type: EXPERIMENTAL
Intervention: Small Incision group
Number of subjects: 44

Group type: COMPARATOR
Intervention: Long Incision group
Number of subjects: 44
Study: 35917985

Group type: EXPERIMENTAL
Intervention: Silver Nanoparticles (AgNPs) alone at 0.04%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Silver Nanoparticles (AgNPs) + Calcium Hydroxide (Ca(OH)2) at 0.03%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Triple antibiotic paste, Calcium Hydroxide, and Saline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing concentrations of Silver Nanoparticles (AgNPs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AgNPs (0.06%) + Calcium Hydroxide (Ca(OH)2)
Number of subjects: 0
Study: 32394653

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at Neiguan (PC 6) and Shuigou (GV 26) with disperse-dense wave, 2 Hz/100 Hz in frequency, 0.1-5 mA in intensity, treatment performed once a day for 14 consecutive days.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group treated with awakening drugs and neurotrophic drugs.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 100
Study: 35418332

Group type: COMPARATOR
Intervention: Surgical mask (SM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Filtering facepiece mask (FFP2)
Number of subjects: 50
Study: 33965733

Group type: EXPERIMENTAL
Intervention: Denial
Number of subjects: 615

Group type: COMPARATOR
Intervention: Decline to respond
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Attack the accuser
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Apology
Number of subjects: 615
Study: 32406162

Group type: EXPERIMENTAL
Intervention: Microneedling plus topical 4% tranexamic acid
Number of subjects: 60

Group type: COMPARATOR
Intervention: Topical 4% hydroquinone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 33084980

Group type: EXPERIMENTAL
Intervention: Calsurf (bovine surfactant)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 328
Study: 33483552

Group type: EXPERIMENTAL
Intervention: Open-label placebos (OLP) applied for 21 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Open-label placebos (OLP)
Number of subjects: 0
Study: 35715486

Group type: EXPERIMENTAL
Intervention: Daily mother-infant skin-to-skin contact (SSC) for one hour during the first five postnatal weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily mother-infant skin-to-skin contact (SSC) (per-protocol analysis)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care-as-usual (per-protocol analysis)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily mother-infant skin-to-skin contact (SSC)
Number of subjects: 0
Study: 33751906

Group type: EXPERIMENTAL
Intervention: l-theanine (single dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: l-theanine (regular intake for 12 weeks)
Number of subjects: 0
Study: 33614993

Group type: EXPERIMENTAL
Intervention: Open narrative followed by closed questions
Number of subjects: 2509

Group type: COMPARATOR
Intervention: Closed questions only
Number of subjects: 2509
Study: 35258744

Group type: EXPERIMENTAL
Intervention: Forearm-mounted handle
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Joystick-and-trigger handle
Number of subjects: 9

Group type: COMPARATOR
Intervention: Standard neurosurgical grasper (control)
Number of subjects: 9
Study: 32321777

Group type: EXPERIMENTAL
Intervention: Preoperative education comprising of a video and ICU tour in addition to standard care
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 100
Study: 32641334

Group type: EXPERIMENTAL
Intervention: IPCAS intervention involving a review of stroke-related needs, a self-management programme, a direct point of contact in general practice, enhanced communication between care services, and a directory of national and local community services.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group) for stroke patients.
Number of subjects: 0
Study: 35219565

Group type: COMPARATOR
Intervention: Skin-only upper blepharoplasty
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Skin/muscle upper blepharoplasty
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Additional muscle resection
Number of subjects: 54
Study: 35476249

Group type: EXPERIMENTAL
Intervention: Ganglionated plexi ablation
Number of subjects: 74

Group type: COMPARATOR
Intervention: Maze procedure without ganglionated plexi ablation
Number of subjects: 74
Study: 33926276

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Drug-coated balloons (DCB)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: PTA with mild dissection
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: DCB with mild dissection
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: PTA with severe dissection
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: DCB with severe dissection
Number of subjects: 144
Study: 35078833

Group type: EXPERIMENTAL
Intervention: Standard care plus care and case management (CCM) for 12 months
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 80
Study: 34096661

Group type: EXPERIMENTAL
Intervention: Cranial microcurrent stimulation (CMS); intensity, 25 μA; frequency, 8 Hz; 20-minute daily treatment for 2 weeks.
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham treatment (no current).
Number of subjects: 22
Study: 32623821

Group type: EXPERIMENTAL
Intervention: Cindolo model
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Leibovich model
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: MSKCC model
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: IMDC model
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: All models
Number of subjects: 515
Study: 36434652

Group type: EXPERIMENTAL
Intervention: Objective Structured Clinical Evaluation (OSCE)
Number of subjects: 86
Study: 33307766

Group type: EXPERIMENTAL
Intervention: Threshold inspiratory muscle training and aerobic exercise (TG)
Number of subjects: 63
Study: 32965478

Group type: EXPERIMENTAL
Intervention: Long-acting injectable antipsychotics
Number of subjects: 368

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 368
Study: 35698001

Group type: EXPERIMENTAL
Intervention: Alfentanil 0.2 μg/kg/min
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Alfentanil 0.4 μg/kg/min
Number of subjects: 172

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Alfentanil 0.2 μg/kg/min vs Normal saline
Number of subjects: 172
Study: 32092065

Group type: EXPERIMENTAL
Intervention: Perspective-taking
Number of subjects: 195

Group type: COMPARATOR
Intervention: Control
Number of subjects: 195

Group type: COMPARATOR
Intervention: Stereotype-suppression
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 195
Study: 36243712

Group type: EXPERIMENTAL
Intervention: 10mg melatonin
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 600mg gabapentin
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 99

Group type: COMPARATOR
Intervention: Starch tablets (Control)
Number of subjects: 99
Study: 34016041

Group type: EXPERIMENTAL
Intervention: Health utility values for all patients
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Health utility values for traders (those willing to lose part of their remaining life to avoid the disease)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Health utility values for elderly patients
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Health utility values for patients living in rural areas
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Statistical significance of socio-demographic factors
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Determinants of COVID-19 health utility value
Number of subjects: 320
Study: 33370476

Group type: EXPERIMENTAL
Intervention: Gypsum cast records
Number of subjects: 10

Group type: COMPARATOR
Intervention: Digital grayscale intra-oral scans
Number of subjects: 10
Study: 32460633

Group type: EXPERIMENTAL
Intervention: Thigh attached wearable resistance (WR) of 2% body mass
Number of subjects: 14
Study: 33781275

Group type: EXPERIMENTAL
Intervention: Fortified formula with n3-PUFA (n=42)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (n=86)
Number of subjects: 128
Study: 35051141

Group type: EXPERIMENTAL
Intervention: Platelet Rich Plasma (PRP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 26
Study: 33059925

Group type: EXPERIMENTAL
Intervention: Closed suction drainage
Number of subjects: 60

Group type: COMPARATOR
Intervention: Undrained group
Number of subjects: 60
Study: 34167659

Group type: EXPERIMENTAL
Intervention: Anodal multichannel tDCS over bilateral TPJ
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study: 32488923

Group type: EXPERIMENTAL
Intervention: Mealtime ultra rapid lispro (URLi)
Number of subjects: 1222

Group type: EXPERIMENTAL
Intervention: Post-meal ultra rapid lispro (URLi)
Number of subjects: 1222

Group type: COMPARATOR
Intervention: Lispro
Number of subjects: 1222

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 1222
Study: 36267030

Group type: EXPERIMENTAL
Intervention: TAP block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Anterior QLB
Number of subjects: 60
Study: 33504040

Group type: EXPERIMENTAL
Intervention: Mirror Therapy Action Observation (MTAO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Action Observation Therapy (AOT)
Number of subjects: 0
Study: 32556550

Group type: EXPERIMENTAL
Intervention: Left upper lobectomy
Number of subjects: 1383

Group type: COMPARATOR
Intervention: Other types of lobectomy
Number of subjects: 1383
Study: 35270396

Group type: EXPERIMENTAL
Intervention: Pre-pregnancy excess weight
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Pre-pregnancy BMI
Number of subjects: 68
Study: 33914296

Group type: EXPERIMENTAL
Intervention: EN3835 (collagenase)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline and methylene blue
Number of subjects: 15
Study: 32881835

Group type: EXPERIMENTAL
Intervention: Resveratrol supplementation (75 mg BID)
Number of subjects: 125
Study: 35627877

Group type: EXPERIMENTAL
Intervention: First person perspective virtual training (experimental group)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Third person perspective (control group)
Number of subjects: 52
Study: 35150524

Group type: EXPERIMENTAL
Intervention: Subtalar mobilisation technique
Number of subjects: 52

Group type: COMPARATOR
Intervention: Therapeutic ultrasound (Control)
Number of subjects: 52
Study: 32742515

Group type: EXPERIMENTAL
Intervention: Haloperidol (0.5 cc, 5 mg)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg, given 30 minutes before surgery)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (25 μg)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Ginger (four capsules with a hint of lemon)
Number of subjects: 88
Study: 36124709

Group type: EXPERIMENTAL
Intervention: Intervention group (IG) - hospital-based lifestyle course and primary care follow-up
Number of subjects: 601

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Intervention group (IG)
Number of subjects: 601
Study: 36277011

Group type: EXPERIMENTAL
Intervention: Metagenomic next-generation sequencing (mNGS)
Number of subjects: 138

Group type: COMPARATOR
Intervention: General bacterial and fungal culture
Number of subjects: 138
Study: 34905431

Group type: EXPERIMENTAL
Intervention: Health Literacy (HL)
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: Health Literacy (HL) and Knowledge
Number of subjects: 579
Study: 35683427

Group type: EXPERIMENTAL
Intervention: Convalescent plasma (600 mL divided into two doses administered on days 1 and 2)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard treatment alone (Control group)
Number of subjects: 54
Study: 33483197

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 32873093

Group type: EXPERIMENTAL
Intervention: Morning BTA injections
Number of subjects: 61

Group type: COMPARATOR
Intervention: Afternoon BTA injections
Number of subjects: 61
Study: 35028684

Group type: EXPERIMENTAL
Intervention: Patient-specific contrast enhancement optimizer simulation software (p-COP)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Conventional contrast material (CM) injection protocol based on body weight
Number of subjects: 102
Study: 34499111

Group type: EXPERIMENTAL
Intervention: Eye examinations and eyeglasses (intervention group, cohort 1)
Number of subjects: 2304

Group type: COMPARATOR
Intervention: Control groups (cohorts 2 and 3)
Number of subjects: 2304
Study: 34982319

Group type: EXPERIMENTAL
Intervention: Mini Addenbrooke's Cognitive Examination (MACE)
Number of subjects: 231

Group type: COMPARATOR
Intervention: International HIV Dementia Scale (IHDS)
Number of subjects: 231
Study: 34406695

Group type: EXPERIMENTAL
Intervention: tDCS (transcranial direct current stimulation)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 77
Study: 32820647

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 608

Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 608
Study: 35298191

Group type: EXPERIMENTAL
Intervention: Strengths-based family program
Number of subjects: 234